Skip to content
PIL Logo

Cimzia 200 mg solution for injection in pre-filled pen

Last Updated on eMC 19-May-2017 View changes  | UCB Pharma Limited Contact details

The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.

Please click on the link to the left to view the PIL in PDF format.

Certain risk materials on this website are intended for use by healthcare professionals only.

By proceeding you are confirming that you are a healthcare professional.

Want to avoid this message? If you are a Healthcare professional, REGISTER or LOGIN and you will not have to self-certify when you access Risk Minimisation Materials.

You can leave feedback on specific Risk Minimisation Materials or make general observations about how they are displayed on the eMC by leaving comments in the box below.

Please note that we are unable to respond to medical queries.

Cimzia 200 mg solution for injection in pre-filled pen


Please enter your email address below

Tick here if you wish to recieve a response to your feedback

Risk Materials
VIEW

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

Cimzia Patient Alert card

This alert card contains important safety information that patients need to be aware of before they are given CIMZIA and during treatment with CIMZIA.

Cimzia Prescriber Guide

Educational Material

For Healthcare Professionals
CLOSE THIS PANEL

Company contact details

UCB Pharma Limited

Company image
Address

208 Bath Road, Slough, Berkshire, SL1 3WE

Medical Information Direct Line

+44 (0) 1753 777 100

Telephone

+ 44 (0) 1753 534655

Medical Information e-mail

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

certolizumab pegol

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue